micron said:You're very inclined to rely on the word of Heras' lawyer, aren't you Bobke? Oh, there's a delay in the test therefore it must be faulty. Turn that around and put yourself in the shoes of the director of the lab - a Spaniard, who is being asked to prove or disprove the innocence of one of Spain's top sportsmen - wouldn't you want to make damn sure that you had crossed every t and dotted every i, because I certainly would.
It looks like the second test could not be read so they are doing a third test. Sound fair to anyone?
Here's from procycling:
Heras and his team spent Wednesday evening building their case for rejection of the test. His lawyer, José Maria Buxeda, who attended the testing procedure, said: “The image of the test could not be read. So the result should be that EPO has not been detected. This provides clear evidence that the method is flawed. The director of the laboratory has decided to repeat the analysis again and in principle the result will be announced on Friday, but what guarantees will that give us?”
Meanwhile Heras, speaking at a press conference in Madrid, commented: “I expected a negative test, but what has happened is that they could not confirm anything… I’ve got a completely clear conscience and I insist I’ve never taken EPO or anything else. It is right there are controls but this method is clearly unreliable.”
He added that it would have been “madness” and “incomprehensible” for him to have taken any doping products on the penultimate stage of a race that he was already leading by well over four minutes.
Late on Wednesday evening, the CSD lab put out a statement of their own, denying reports that the initial testing had been inconclusive. “The remaining quantity of the sample and the perfect method of storage are allowing the analytical process to continue, a decision that the doping control laboratory has taken in conjunction with the scientific expert from the International Cycling Union.”
The lab made clear in comments to the Spanish press that it is not unusual to restart the testing procedure in cases like this in order to guarantee that the correct result in what is recognised as a complex test is achieved. WADA itself backs this strategy.
What is unusual is the degree of outside interest at this stage of the testing process, and the announcement to the press by Heras’s lawyer that the test was inconclusive and was “surprisingly” set to be repeated. He has already asked the lab and the UCI to nullify the second test of the counter-analysis on the basis that it is a new test; in effect, a third test.